只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 2026-07-15 | GRAB Grab Holdings Ltd | Kandal Philipp Wolfgang Josef Officer · Chief Product Officer | 卖出（S） | 30,000 | US$3.83 | US$114,945.00 | 4,018,735 | SEC |
| 2026-07-13 2026-07-15 | GRAB Grab Holdings Ltd | Kandal Philipp Wolfgang Josef Officer · Chief Product Officer | 卖出（S） | 20,000 | US$4.00 | US$80,000.00 | 4,048,735 | SEC |
| 2026-07-07 2026-07-08 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 107,429 | US$0.31 | US$33,302.99 | 0 | SEC |
| 2026-07-07 2026-07-07 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 287,815 | US$17.10 | US$492.28万 | 2,663,349 | SEC |
| 2026-07-07 2026-07-07 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 28,465 | US$17.10 | US$486,865.36 | 217,930 | SEC |
| 2026-07-06 2026-07-08 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 35,770 | US$0.32 | US$11,446.40 | 107,429 | SEC |
| 2026-07-06 2026-07-07 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 50,834 | US$16.92 | US$859,857.11 | 2,951,164 | SEC |
| 2026-07-06 2026-07-07 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 5,027 | US$16.92 | US$85,031.71 | 246,395 | SEC |
| 2026-07-02 2026-07-07 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 136,500 | US$16.83 | US$229.67万 | 3,001,998 | SEC |
| 2026-07-02 2026-07-07 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 13,500 | US$16.83 | US$227,151.00 | 251,422 | SEC |
| 2026-07-02 2026-07-06 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 415 | US$0.49 | US$204.18 | 734,875 | SEC |
| 2026-07-02 2026-07-06 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 4 | US$0.49 | US$1.97 | 734,871 | SEC |
| 2026-07-02 2026-07-06 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 712 | US$0.49 | US$350.30 | 734,159 | SEC |
| 2026-06-29 2026-06-29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 157,084 | US$0.30 | US$47,125.20 | 143,199 | SEC |
| 2026-06-25 2026-06-29 | STRL STERLING INFRASTRUCTURE, INC. | Wolf Mark D. Officer · General Counsel, Corporate Sec | 卖出（S） | 2,500 | US$888.00 | US$222万 | 28,137 | SEC |
| 2026-06-17 2026-06-22 | BURL Burlington Stores, Inc. | Wolfe Kristin Officer · Chief Financial Officer | 卖出（S） | 3,210 | US$341.10 | US$109.49万 | 26,892 | SEC |
| 2026-06-17 2026-06-22 | BURL Burlington Stores, Inc. | Wolfe Kristin Officer · Chief Financial Officer | 卖出（S） | 2,930 | US$339.10 | US$993,563.00 | 32,162 | SEC |
| 2026-06-17 2026-06-22 | BURL Burlington Stores, Inc. | Wolfe Kristin Officer · Chief Financial Officer | 卖出（S） | 2,060 | US$340.34 | US$701,100.40 | 30,102 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 389,216 | US$0.35 | US$136,225.60 | 4,268,448 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 389,216 | US$0.35 | US$136,225.60 | 4,268,448 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 389,216 | US$0.35 | US$136,225.60 | 4,268,448 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 389,216 | US$0.35 | US$136,225.60 | 4,268,448 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 27,695 | US$0.35 | US$9,693.25 | 303,719 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 27,695 | US$0.35 | US$9,693.25 | 303,719 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 27,695 | US$0.35 | US$9,693.25 | 303,719 | SEC |
| 2026-06-17 2026-06-22 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 27,695 | US$0.35 | US$9,693.25 | 303,719 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 139,686 | US$0.37 | US$51,683.82 | 4,657,664 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 139,686 | US$0.37 | US$51,683.82 | 4,657,664 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 139,686 | US$0.37 | US$51,683.82 | 4,657,664 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 139,686 | US$0.37 | US$51,683.82 | 4,657,664 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 9,939 | US$0.37 | US$3,677.43 | 331,414 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 9,939 | US$0.37 | US$3,677.43 | 331,414 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 9,939 | US$0.37 | US$3,677.43 | 331,414 | SEC |
| 2026-06-16 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 9,939 | US$0.37 | US$3,677.43 | 331,414 | SEC |
| 2026-06-15 2026-06-17 | GRAB Grab Holdings Ltd | Kandal Philipp Wolfgang Josef Officer · Chief Product Officer | 卖出（S） | 30,000 | US$3.53 | US$105,900.00 | 4,065,430 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 120,216 | US$0.39 | US$46,884.24 | 4,797,350 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 120,216 | US$0.39 | US$46,884.24 | 4,797,350 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 120,216 | US$0.39 | US$46,884.24 | 4,797,350 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 120,216 | US$0.39 | US$46,884.24 | 4,797,350 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 8,554 | US$0.39 | US$3,336.06 | 341,353 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 8,554 | US$0.39 | US$3,336.06 | 341,353 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 8,554 | US$0.39 | US$3,336.06 | 341,353 | SEC |
| 2026-06-15 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 8,554 | US$0.39 | US$3,336.06 | 341,353 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 159,119 | US$0.40 | US$63,647.60 | 4,917,566 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 159,119 | US$0.40 | US$63,647.60 | 4,917,566 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 159,119 | US$0.40 | US$63,647.60 | 4,917,566 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 159,119 | US$0.40 | US$63,647.60 | 4,917,566 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 11,322 | US$0.40 | US$4,528.80 | 349,907 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 11,322 | US$0.40 | US$4,528.80 | 349,907 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 11,322 | US$0.40 | US$4,528.80 | 349,907 | SEC |
| 2026-06-12 2026-06-16 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 11,322 | US$0.40 | US$4,528.80 | 349,907 | SEC |
| 2026-06-12 2026-06-12 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 293,774 | US$17.40 | US$511.17万 | 3,138,498 | SEC |
| 2026-06-12 2026-06-12 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 29,055 | US$17.40 | US$505,557.00 | 264,922 | SEC |
| 2026-06-11 2026-06-12 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 191,893 | US$17.02 | US$326.6万 | 3,432,272 | SEC |
| 2026-06-11 2026-06-12 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 18,978 | US$17.02 | US$323,005.56 | 293,977 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 17,437 | US$0.38 | US$6,626.06 | 361,229 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 17,437 | US$0.38 | US$6,626.06 | 361,229 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 17,437 | US$0.38 | US$6,626.06 | 361,229 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 17,437 | US$0.38 | US$6,626.06 | 361,229 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 245,066 | US$0.38 | US$93,125.08 | 5,076,685 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 245,066 | US$0.38 | US$93,125.08 | 5,076,685 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 245,066 | US$0.38 | US$93,125.08 | 5,076,685 | SEC |
| 2026-06-11 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 245,066 | US$0.38 | US$93,125.08 | 5,076,685 | SEC |
| 2026-06-10 2026-06-12 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 25,301 | US$16.93 | US$428,345.93 | 312,955 | SEC |
| 2026-06-10 2026-06-12 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 255,816 | US$16.93 | US$433.1万 | 3,624,165 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 42,872 | US$0.37 | US$15,862.64 | 5,321,751 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 42,872 | US$0.37 | US$15,862.64 | 5,321,751 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 42,872 | US$0.37 | US$15,862.64 | 5,321,751 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 42,872 | US$0.37 | US$15,862.64 | 5,321,751 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 3,051 | US$0.37 | US$1,128.87 | 378,666 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 3,051 | US$0.37 | US$1,128.87 | 378,666 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 3,051 | US$0.37 | US$1,128.87 | 378,666 | SEC |
| 2026-06-10 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 3,051 | US$0.37 | US$1,128.87 | 378,666 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 345,235 | US$0.37 | US$127,736.95 | 5,364,623 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 345,235 | US$0.37 | US$127,736.95 | 5,364,623 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 345,235 | US$0.37 | US$127,736.95 | 5,364,623 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 345,235 | US$0.37 | US$127,736.95 | 5,364,623 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 24,565 | US$0.37 | US$9,089.05 | 381,717 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 24,565 | US$0.37 | US$9,089.05 | 381,717 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 24,565 | US$0.37 | US$9,089.05 | 381,717 | SEC |
| 2026-06-09 2026-06-11 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 24,565 | US$0.37 | US$9,089.05 | 381,717 | SEC |
| 2026-06-09 2026-06-10 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 76,928 | US$0.37 | US$28,463.36 | 300,283 | SEC |
| 2026-06-08 2026-06-08 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 60,547 | US$0.40 | US$24,218.80 | 377,211 | SEC |
| 2026-06-05 2026-06-08 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 24,946 | US$0.40 | US$9,978.40 | 437,758 | SEC |
| 2026-06-04 2026-06-08 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 20,072 | US$0.44 | US$8,831.68 | 462,704 | SEC |
| 2026-06-03 2026-06-03 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 29,749 | US$0.42 | US$12,494.58 | 482,776 | SEC |
| 2026-06-02 2026-06-03 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 29,595 | US$0.45 | US$13,317.75 | 512,525 | SEC |
| 2026-06-02 2026-06-03 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 6 | US$0.91 | US$5.46 | 731,094 | SEC |
| 2026-06-02 2026-06-03 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 824 | US$0.91 | US$749.84 | 731,100 | SEC |
| 2026-06-02 2026-06-03 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 480 | US$0.91 | US$436.80 | 731,924 | SEC |
| 2026-06-01 2026-06-03 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 80,459 | US$0.47 | US$37,815.73 | 542,120 | SEC |
| 2026-05-29 2026-05-29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 32,556 | US$0.45 | US$14,650.20 | 622,579 | SEC |
| 2026-05-28 2026-05-29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 27,698 | US$0.46 | US$12,741.08 | 655,135 | SEC |
| 2026-05-27 2026-05-29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 80,852 | US$0.48 | US$38,808.96 | 682,833 | SEC |
| 2026-05-27 2026-05-28 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 21,954 | US$15.67 | US$344,019.18 | 338,256 | SEC |
| 2026-05-27 2026-05-28 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 221,984 | US$15.67 | US$347.85万 | 5,379,981 | SEC |
| 2026-05-26 2026-05-26 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 67,950 | US$0.47 | US$31,936.50 | 763,685 | SEC |
| 2026-05-22 2026-05-26 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 87,425 | US$0.45 | US$39,341.25 | 831,635 | SEC |
| 2026-05-22 2026-05-26 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 3,643 | US$15.62 | US$56,903.66 | 360,210 | SEC |
| 2026-05-22 2026-05-26 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 36,833 | US$15.62 | US$575,331.46 | 5,601,965 | SEC |
| 2026-05-21 2026-05-26 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 36,387 | US$0.42 | US$15,282.54 | 919,060 | SEC |
| 2026-05-20 2026-05-21 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 3,126 | US$1.21 | US$3,782.46 | 728,208 | SEC |
| 2026-05-20 2026-05-20 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 85,895 | US$0.43 | US$36,934.85 | 955,447 | SEC |
| 2026-05-19 2026-05-20 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 62,970 | US$0.45 | US$28,336.50 | 1,041,342 | SEC |
| 2026-05-18 2026-05-20 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 22,184 | US$0.50 | US$11,092.00 | 1,104,312 | SEC |
| 2026-05-15 2026-05-19 | GRAB Grab Holdings Ltd | Kandal Philipp Wolfgang Josef Officer · Chief Product Officer | 卖出（S） | 30,000 | US$3.54 | US$106,200.00 | 4,095,430 | SEC |
| 2026-05-13 2026-05-13 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 44,679 | US$0.54 | US$24,126.66 | 1,126,496 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 67,885 | US$0.64 | US$43,446.40 | 1,171,175 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 6,719 | US$0.64 | US$4,300.16 | 406,282 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 6,719 | US$0.64 | US$4,300.16 | 406,282 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 6,719 | US$0.64 | US$4,300.16 | 406,282 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 6,719 | US$0.64 | US$4,300.16 | 406,282 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 94,432 | US$0.64 | US$60,436.48 | 5,709,858 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 94,432 | US$0.64 | US$60,436.48 | 5,709,858 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 94,432 | US$0.64 | US$60,436.48 | 5,709,858 | SEC |
| 2026-05-12 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 94,432 | US$0.64 | US$60,436.48 | 5,709,858 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 33,948 | US$0.67 | US$22,745.16 | 1,239,060 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 5,812 | US$0.67 | US$3,894.04 | 413,001 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 5,812 | US$0.67 | US$3,894.04 | 413,001 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 5,812 | US$0.67 | US$3,894.04 | 413,001 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 5,812 | US$0.67 | US$3,894.04 | 413,001 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 81,678 | US$0.67 | US$54,724.26 | 5,804,290 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 81,678 | US$0.67 | US$54,724.26 | 5,804,290 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 81,678 | US$0.67 | US$54,724.26 | 5,804,290 | SEC |
| 2026-05-11 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 81,678 | US$0.67 | US$54,724.26 | 5,804,290 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 305,741 | US$0.70 | US$214,018.70 | 1,273,008 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 351,514 | US$0.71 | US$249,574.94 | 5,885,968 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 351,514 | US$0.71 | US$249,574.94 | 5,885,968 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 351,514 | US$0.71 | US$249,574.94 | 5,885,968 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 351,514 | US$0.71 | US$249,574.94 | 5,885,968 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 卖出（S） | 25,012 | US$0.71 | US$17,758.52 | 418,813 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Shah Rajeev M. TenPercentOwner | 卖出（S） | 25,012 | US$0.71 | US$17,758.52 | 418,813 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | Kolchinsky Peter TenPercentOwner | 卖出（S） | 25,012 | US$0.71 | US$17,758.52 | 418,813 | SEC |
| 2026-05-08 2026-05-12 | HOWL Werewolf Therapeutics, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 卖出（S） | 25,012 | US$0.71 | US$17,758.52 | 418,813 | SEC |
| 2026-05-08 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 35,025 | US$15.69 | US$549,542.25 | 363,853 | SEC |
| 2026-05-08 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 354,136 | US$15.69 | US$555.64万 | 5,638,798 | SEC |
| 2026-05-07 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 543,474 | US$15.59 | US$847.28万 | 5,992,934 | SEC |
| 2026-05-07 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 53,750 | US$15.59 | US$837,962.50 | 398,878 | SEC |
| 2026-05-07 2026-05-07 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 79,086 | US$0.63 | US$49,824.18 | 1,578,749 | SEC |
| 2026-05-06 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 69,891 | US$14.47 | US$101.13万 | 469,727 | SEC |
| 2026-05-06 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 172,890 | US$15.01 | US$259.51万 | 6,536,408 | SEC |
| 2026-05-06 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 706,681 | US$14.47 | US$1022.57万 | 6,709,298 | SEC |
| 2026-05-06 2026-05-08 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 17,099 | US$15.01 | US$256,655.99 | 452,628 | SEC |
| 2026-05-06 2026-05-07 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 14,635 | US$0.66 | US$9,659.10 | 1,657,835 | SEC |
| 2026-05-06 2026-05-07 | WCC WESCO INTERNATIONAL INC | Wolf Christine Ann Officer · EVP & CHRO | 卖出（S） | 2,549 | US$355.25 | US$905,532.25 | 29,570.2 | SEC |
| 2026-05-05 2026-05-07 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 6,860 | US$0.69 | US$4,733.40 | 1,672,470 | SEC |
| 2026-05-05 2026-05-07 | WCC WESCO INTERNATIONAL INC | Wolf Christine Ann Officer · EVP & CHRO | 卖出（S） | 2,438 | US$351.16 | US$856,128.08 | 29,570.2 | SEC |
| 2026-05-04 2026-05-05 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 1,947 | US$1.42 | US$2,764.74 | 730,639 | SEC |
| 2026-05-04 2026-05-05 | NLY ANNALY CAPITAL MANAGEMENT INC | Wolfe Serena Officer · Chief Financial Officer | 卖出（S） | 16,537 | US$22.48 | US$371,751.76 | 200,964 | SEC |
| 2026-05-04 2026-05-04 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 47,963 | US$0.72 | US$34,533.36 | 1,679,330 | SEC |
| 2026-05-01 2026-05-04 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 58,394 | US$0.73 | US$42,627.62 | 1,727,293 | SEC |
| 2026-04-30 2026-05-04 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 168,262 | US$0.72 | US$121,148.64 | 1,785,687 | SEC |
| 2026-04-29 2026-04-29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 56,559 | US$0.69 | US$39,025.71 | 1,953,949 | SEC |
| 2026-04-28 2026-04-29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 95,412 | US$0.73 | US$69,650.76 | 2,010,508 | SEC |
| 2026-04-27 2026-04-29 | HOWL Werewolf Therapeutics, Inc. | EVNIN LUKE Director | 卖出（S） | 53,940 | US$0.85 | US$45,849.00 | 2,105,920 | SEC |
| 2026-04-20 2026-04-21 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 236 | US$1.50 | US$354.00 | 728,389 | SEC |
| 2026-04-16 2026-04-17 | GRAB Grab Holdings Ltd | Kandal Philipp Wolfgang Josef Officer · Chief Product Officer | 卖出（S） | 20,000 | US$4.00 | US$80,000.00 | 4,125,430 | SEC |
| 2026-04-15 2026-04-17 | GRAB Grab Holdings Ltd | Kandal Philipp Wolfgang Josef Officer · Chief Product Officer | 卖出（S） | 30,000 | US$3.92 | US$117,600.00 | 4,145,430 | SEC |
| 2026-04-02 2026-04-03 | FLD Fold Holdings, Inc. | Repass Wolfe Officer · Chief Financial Officer | 卖出（S） | 1,326 | US$1.22 | US$1,617.72 | 245,641 | SEC |
| 2026-04-02 2026-04-03 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 3,593 | US$11.14 | US$40,026.02 | 539,618 | SEC |
| 2026-04-02 2026-04-03 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 36,326 | US$11.14 | US$404,671.64 | 7,415,979 | SEC |
| 2026-04-01 2026-04-03 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 14,426 | US$11.06 | US$159,551.56 | 543,211 | SEC |
| 2026-04-01 2026-04-03 | PBI PITNEY BOWES INC /DE/ | Wolf Kurt James Director,Officer · President & CEO | 卖出（S） | 145,863 | US$11.06 | US$161.32万 | 7,452,305 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| WOLF | 735,504.6423 | 2,801 | 1,495,275.8675 | 49.19% | B, Q, N |